申请人:Eatherton Andrew John
公开号:US20080221097A1
公开(公告)日:2008-09-11
The present invention relates to novel imidazopyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
本发明涉及新型咪唑吡啶衍生物、含有这些化合物的制药组合物以及它们在治疗疾病中的应用,特别是与大麻素受体活性的增加或减少直接或间接相关的疾病,尤其是疼痛。